Yahoo
NYSE - Delayed Quote USD

Avantor, Inc. (AVTR)

7.96 -0.14 (-1.73%)
At close: May 1 at 4:00:03 PM EDT
8.02 +0.06 (+0.74%)
After hours: May 1 at 7:52:03 PM EDT
Trade Avantor on Coinbase
Chart Range Bar
Loading chart for AVTR
  • Previous Close 8.10
  • Open 8.13
  • Bid --
  • Ask --
  • Day's Range 7.85 - 8.22
  • 52 Week Range 7.26 - 15.93
  • Volume 9,275,520
  • Avg. Volume 10,615,501
  • Market Cap (intraday) 5.435B
  • Beta (5Y Monthly) 1.00
  • PE Ratio (TTM) --
  • EPS (TTM) -0.81
  • Earnings Date Apr 29, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 9.92

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

www.avantorsciences.com

13,500

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview: AVTR

Trailing total returns as of 5/1/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

AVTR
30.54%
S&P 500 (^GSPC)
5.62%

1-Year Return

AVTR
38.58%
S&P 500 (^GSPC)
29.01%

3-Year Return

AVTR
60.65%
S&P 500 (^GSPC)
73.47%

5-Year Return

AVTR
75.16%
S&P 500 (^GSPC)
72.92%

Earnings Trends: AVTR

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 1.58B
Earnings 114M

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
500M
1B
2B

Analyst Insights: AVTR

View More

Analyst Price Targets

7.00
9.92 Average
7.96 Current
19.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 4/30/2026
Analyst Citigroup
Rating Action Maintains
Rating Neutral
Price Action Lowers
Price Target 11 -> 9

Statistics: AVTR

View More

Valuation Measures

Annual
As of 5/1/2026
  • Market Cap

    5.43B

  • Enterprise Value

    8.97B

  • Trailing P/E

    --

  • Forward P/E

    8.30

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.83

  • Price/Book (mrq)

    0.97

  • Enterprise Value/Revenue

    1.37

  • Enterprise Value/EBITDA

    78.36

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -8.42%

  • Return on Assets (ttm)

    2.79%

  • Return on Equity (ttm)

    -9.44%

  • Revenue (ttm)

    6.55B

  • Net Income Avi to Common (ttm)

    -551.4M

  • Diluted EPS (ttm)

    -0.81

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    279.3M

  • Total Debt/Equity (mrq)

    68.29%

  • Levered Free Cash Flow (ttm)

    490.49M

Compare To: AVTR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights: AVTR

Fair Value

7.96 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports: AVTR

View More
  • Lowering target price to $7.00

    AVANTOR INC has an Investment Rating of HOLD; a target price of $7.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Price Target
  • What does Argus have to say about AVTR?

    AVANTOR INC has an Investment Rating of HOLD; a target price of $8.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Price Target
  • What does Argus have to say about AVTR?

    AVANTOR INC has an Investment Rating of HOLD; a target price of $8.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Price Target
  • Raising target price to $8.00

    AVANTOR INC has an Investment Rating of HOLD; a target price of $8.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.

    Rating
    Price Target

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: